FDA approves generic AIDS drug

December 20, 2007

The U.S. Food and Drug Administration has given tentative approval for a generic version of the AIDS drug Viread.

The approval means that generic tablets of tenofovir disoproxil fumarate can be considered for purchase under the President's Emergency Plan for AIDS Relief (PEPFAR), a five-year, $15 billion effort to fight the HIV/AIDS pandemic, the FDA said Wednesday.

"The fight to save lives with high-quality anti-retroviral treatment is of significant importance to FDA," Gary Buehler, director of FDA's Office of Generic Drugs, said in a release. "Our scientists have been working diligently to make safe and effective treatments for AIDS available as quickly as possible to combat this worldwide problem."

The tenofovir disoproxil fumarate 300 milligram tablets are manufactured by Matrix Laboratories, LTD, of Andhra Pradesh, India.

The FDA said PEPFAR has helped provide anti-retroviral treatment for a total of more than 1.3 million men, women and children in 15 focus countries in sub-Saharan Africa, Asia and the Caribbean.

Copyright 2007 by United Press International

Explore further: Generic drugs key to US overseas HIV relief: researchers

Related Stories

Generic drugs key to US overseas HIV relief: researchers

July 9, 2012
The President's Emergency Plan for AIDS Relief (PEPfAR) began in 2003 with good intentions, but it was not until the U.S. government's massive overseas public health campaign adopted generic drugs that it became a success, ...

Thirty years of AIDS: A timeline of the epidemic

June 8, 2011
Thirty years into the fight against HIV/AIDS, UCSF has helped change the course of this deadly disease, which has claimed the lives of 33 million people worldwide. This timeline covers the highlights over the past three ...

AIDS fight enters new phase with prevention pill

May 11, 2012
(AP) -- Condoms and other safe-sex practices have accomplished only so much. Now the 30-year battle against AIDS is on the verge of a radical new phase, with the government expected to endorse a once-a-day pill to prevent ...

FDA seizes counterfeit drugs, devices sold online

June 19, 2015
(HealthDay)—The U.S. Food and Drug Administration, along with international partners, moved this week against more than 1,050 websites that sell potentially dangerous counterfeit medicines and medical devices, the agency ...

Child-friendly formulation of WHO-recommended HIV treatment approved by FDA

June 4, 2015
The Paediatric HIV Treatment Initiative welcomes this important step towards closing the treatment gap for children with HIV

Drug distribution becomes weapon to block competition

March 3, 2016
The same strategy that Martin Shkreli used to get away with a 5,000-percent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on billions of dollars' worth of medications.

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.